期刊文献+

观察艾司西酞普兰治疗首发女性抑郁症的有效性及对患者睡眠质量的影响 被引量:1

To Observe the Efficacy of Escitalopram in the Treatment of First-episode Female Depression and its Effect on Sleep Quality
下载PDF
导出
摘要 目的:观察艾司西酞普兰治疗首发女性抑郁症的有效性及对患者睡眠质量的影响。方法:选取2019年1月至2021年1月东莞市第七人民医院收治的首次发病女性抑郁症患者80例作为研究对象,按照随机数字表法分为观察组和对照组,每组40例。对照组给予患者米氮平片治疗,观察组给予艾司西酞普兰进行治疗。采用汉密尔顿焦虑量表(Hamilton Anxiely Scale,HAMA)、汉密尔顿抑郁量表(Hamilton Depression Rating Scale;HAMD)比较2组患者干预前后焦虑、抑郁情绪改善情况,采用匹兹堡睡眠指数量表(Pittsburgh Sleep Quality Index,PSQI)比较2组患者干预前后睡眠质量变化,同时比较2组患者不良反应发生率。结果:治疗后,2组患者PSQI评分、HAMA评分、HAMD评分均有所降低,但观察组显著低于对照组,观察组不良反应发生率显著低于对照组,2组比较差异均有统计学意义(P<0.05)。结论:艾司西酞普兰治疗首发女性抑郁症患者疗效显著,起效更快,且药物安全性高,能够有效改善患者焦虑、抑郁状态,提高睡眠质量,值得临床推广使用。 Objective:To observe the efficacy of escitalopram in the treatment of first-episode female depression and its effect on sleep quality.Methods:A total of 80 female patients with first-time depression admitted to the Seventh People′s Hospital of Dongguan city from January 2019 to January 2021 were selected as the research objects,and were divided into observation group and control group according to the random number table method,with 40 cases in each group.Patients in the control group were treated with mirtazapine tablets,and patients in the observation group were treated with escitepram.Hamilton Anxiely Scale(HAMA),Hamilton Depression Rating Scale(HAMD)to compare the improvement of anxiety and depression between 2 groups before and after intervention.Pittsburgh Sleep Quality Index(PSQI)was used to compare the changes of Sleep Quality in 2 groups before and after intervention,and the incidence of the adverse reactions in 2 groups was compared at the same time.Results:After treatment,PSQI score,HAMA score and HAMD score in 2 groups were decreased,but the observation group was significantly lower than the control group,and the incidence of adverse reactions in the observation group was significantly lower than the control group,the differences between 2 groups were statistically significant(P<0.05).Conclusion:Escitalopram has significant efficacy in the treatment of first-episode female patients with depression,with faster onset and high safety.It can effectively improve anxiety and depression status,and improve sleep quality,which is worthy of clinical application.
作者 张少霞 杨茂增 梁苑施 李一凡 谢益潮 ZHANG Shaoxia;YANG Maozeng;LIANG Yuanshi;LI Yifan;XIE Yichao(The Seventh People′s Hospital of Dongguan,Dongguan 523000,China)
出处 《世界睡眠医学杂志》 2022年第5期854-856,共3页 World Journal of Sleep Medicine
基金 东莞市社会科技发展项目(202050715006019)。
关键词 艾司西酞普兰 抑郁 焦虑 睡眠质量 Escitalopram Depression Anxiety The quality of sleep
  • 相关文献

参考文献12

二级参考文献144

  • 1张智,李传龙,陈辉.西酞普兰联合米氮平治疗抑郁症患者睡眠障碍临床疗效观察[J].心理月刊,2019,0(22):86-86. 被引量:1
  • 2吴士文,杨光,金民,郭军红,于生元.脑梗死患者血清褪黑素节律改变与卒中后日间过度倦睡[J].中风与神经疾病杂志,2004,21(6):538-540. 被引量:20
  • 3王伟.rTMS技术在精神和神经科临床的应用[J].神经疾病与精神卫生,2007,7(3):233-236. 被引量:22
  • 4Murdoch D, Keam SJ. Escitalopram: a review of its use in the management of major depressive disorder. Drugs, 2005; 65 (16) : 2379-2404.
  • 5Khan MNS. Comparison of escitalopram with clomipramine in major depressive disorder: a double blind study. Pakistan Journal Medical Science, 2004; 20 (3): 238-241.
  • 6Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. International Clinical Psychopharmacology, 2005; 20: 131-137.
  • 7Lepola UM, Loft H, Reines EH. Escitalopram (10 - 20mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. International Clinical Psychopharmacology, 2003; 18: 211-217.
  • 8Baldwin DS, Cooper JA, Huusom A. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. International Clinical Psychopharmacology, 2006; 21:159-169.
  • 9Montgomery SA, Anderson HF. Escitalopram versus venlafaxine XR in the treatment of depression. International Clinical Psychopharmacology, 2006; 21: 297-309.
  • 10Bielski RI, Ventura D, Chang CC. A double-blind comparison of esciaflopram and venlafaxine XR in the treatment of major depressive disorder. Journal of Clinical Psychiatry, 2004; 65: 1190-1196.

共引文献268

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部